Walter Bushnell Medivin Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 45.78%
(FY 2022)
- Profit 6.68%
(FY 2022)
- Ebitda -5.93%
(FY 2022)
- Net Worth 50.78%
(FY 2022)
- Total Assets 21.64%
(FY 2022)
About Walter Bushnell Medivin
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Satish Murgai, Prakash Sabherwal, and Brij Nandan serve as directors at the Company.
- CIN/LLPIN
U74999HR2019PTC079003
- Company No.
079003
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Mar 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Walter Bushnell Medivin?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satish Murgai  | Director | 17-Aug-2020 | Current |
| Prakash Sabherwal | Director | 08-Mar-2019 | Current |
| Brij Nandan | Director | 08-Mar-2019 | Current |
Financial Performance and Corporate Structure Insights of Walter Bushnell Medivin.
Walter Bushnell Medivin Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 45.78% increase. The company also saw a slight improvement in profitability, with a 6.68% increase in profit. The company's net worth Soared by an impressive increase of 50.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Walter Bushnell Medivin?
In 2020, Walter Bushnell Medivin had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Walter Bushnell Medisafe Private LimitedActive 16 years 8 monthsSatish Murgai and Prakash Sabherwal are mutual person
Walter Bushnell Pharmaceuticals Private LimitedActive 20 years 10 daysSatish Murgai is a mutual person
Walter Bushnell Healthsciences Private LimitedActive 17 years 5 monthsPrakash Sabherwal and Brij Nandan are mutual person
Walter Bushnell Biosciences Private LimitedActive 17 years 5 monthsPrakash Sabherwal and Brij Nandan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Walter Bushnell Medivin?
Walter Bushnell Medivin has a workforce of 184 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Walter Bushnell Medivin, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Walter Bushnell Medivin's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
